Cancer won't wait: building resilience in cancer screening and diagnostics in Europe based on lessons from the pandemic

Cancer won't wait: building resilience in cancer screening and diagnostics in Europe based on lessons from the pandemic The ongoing impact of Covid-19 on health services across Europe has in most cases led to significant reductions in cancer screening, testing and diagnosis. Responses in individual countries have differed, but there are common challenges in all countries. This report highlights some of the approaches already being taken, as well as suggestions for what should be done going forward. It considers different stakeholders – from local pharmacies to national and international organisations – and their roles, as well as multi-stakeholder collaboration and cooperation. Please note that free registration is required to access this report. The IQVIA Institute